Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response

After neoadjuvant chemoradiotherapy for esophageal adenocarcinoma, up to 29% of patients have a pathological complete response (pCR). What to do afterward is still under debate. The aim of this prospective study was to define which local markers of immune response might act as predictors of pCR and...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncoimmunology
Huvudupphovsmän: Kotsafti, Andromachi, Scarpa, Melania, Cavallin, Francesco, Fassan, Matteo, Salmaso, Roberta, Porzionato, Andrea, Saadeh, Luca, Cagol, Matteo, Alfieri, Rita, Castoro, Carlo, Rugge, Massimo, Castagliuolo, Ignazio, Scarpa, Marco
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7458640/
https://ncbi.nlm.nih.gov/pubmed/32923165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1804169
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk